Airsculpt Technologies Inc
NASDAQ:AIRS
Airsculpt Technologies Inc
Revenue
Airsculpt Technologies Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Airsculpt Technologies Inc
NASDAQ:AIRS
|
Revenue
$195.9m
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Revenue
$12.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Revenue
$9.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
CVS Health Corp
NYSE:CVS
|
Revenue
$357.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
Cigna Corp
NYSE:CI
|
Revenue
$195.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
32%
|
CAGR 10-Years
20%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Revenue
$12.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
See Also
What is Airsculpt Technologies Inc's Revenue?
Revenue
195.9m
USD
Based on the financial report for Dec 31, 2023, Airsculpt Technologies Inc's Revenue amounts to 195.9m USD.
What is Airsculpt Technologies Inc's Revenue growth rate?
Revenue CAGR 3Y
46%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Airsculpt Technologies Inc have been 46% over the past three years .